BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

224 related articles for article (PubMed ID: 37414490)

  • 1. Functional MRI markers for treatment-resistant depression: Insights and challenges.
    Kotoula V; Evans JW; Punturieri C; Johnson SC; Zarate CA
    Prog Brain Res; 2023; 278():117-148. PubMed ID: 37414490
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of Ketamine in Elderly Patients with Treatment-Resistant Depression.
    Medeiros da Frota Ribeiro C; Riva-Posse P
    Curr Psychiatry Rep; 2017 Nov; 19(12):107. PubMed ID: 29138992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Therapeutic options for treatment-resistant depression.
    Shelton RC; Osuntokun O; Heinloth AN; Corya SA
    CNS Drugs; 2010 Feb; 24(2):131-61. PubMed ID: 20088620
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Connectivity-Guided Theta Burst Transcranial Magnetic Stimulation Versus Repetitive Transcranial Magnetic Stimulation for Treatment-Resistant Moderate to Severe Depression: Magnetic Resonance Imaging Protocol and SARS-CoV-2-Induced Changes for a Randomized Double-blind Controlled Trial.
    Pszczolkowski S; Cottam WJ; Briley PM; Iwabuchi SJ; Kaylor-Hughes C; Shalabi A; Babourina-Brooks B; Berrington A; Barber S; Suazo Di Paola A; Blamire A; McAllister-Williams RH; Parikh J; Abdelghani M; Matthäus L; Hauffe R; Liddle P; Auer DP; Morriss R
    JMIR Res Protoc; 2022 Jan; 11(1):e31925. PubMed ID: 35049517
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impaired prefronto-thalamic functional connectivity as a key feature of treatment-resistant depression: a combined MEG, PET and rTMS study.
    Li CT; Chen LF; Tu PC; Wang SJ; Chen MH; Su TP; Hsieh JC
    PLoS One; 2013; 8(8):e70089. PubMed ID: 23936378
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Repetitive Transcranial Magnetic Stimulation for People With Treatment-Resistant Depression: A Health Technology Assessment.
    Ontario Health (Quality)
    Ont Health Technol Assess Ser; 2021; 21(4):1-232. PubMed ID: 34055112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency-specific alterations in functional connectivity in treatment-resistant and -sensitive major depressive disorder.
    He Z; Cui Q; Zheng J; Duan X; Pang Y; Gao Q; Han S; Long Z; Wang Y; Li J; Wang X; Zhao J; Chen H
    J Psychiatr Res; 2016 Nov; 82():30-9. PubMed ID: 27459030
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antidepressant-resistant depression is characterized by reduced short- and long-interval cortical inhibition.
    Jeng JS; Li CT; Lin HC; Tsai SJ; Bai YM; Su TP; Chang YW; Cheng CM
    Psychol Med; 2020 Jun; 50(8):1285-1291. PubMed ID: 31155020
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neuromodulation for treatment-resistant depression: Functional network targets contributing to antidepressive outcomes.
    Idlett-Ali SL; Salazar CA; Bell MS; Short EB; Rowland NC
    Front Hum Neurosci; 2023; 17():1125074. PubMed ID: 36936612
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain volumetric correlates of electroconvulsive therapy versus transcranial magnetic stimulation for treatment-resistant depression.
    Cano M; Lee E; Polanco C; Barbour T; Ellard KK; Andreou B; Uribe S; Henry ME; Seiner S; Cardoner N; Soriano-Mas C; Camprodon JA
    J Affect Disord; 2023 Jul; 333():140-146. PubMed ID: 37024015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Seizure Induced by Deep Transcranial Magnetic Stimulation in an Adolescent with Depression.
    Cullen KR; Jasberg S; Nelson B; Klimes-Dougan B; Lim KO; Croarkin PE
    J Child Adolesc Psychopharmacol; 2016 Sep; 26(7):637-41. PubMed ID: 27447245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A resting-state study of volumetric and functional connectivity of the habenular nucleus in treatment-resistant depression patients.
    Luan SX; Zhang L; Wang R; Zhao H; Liu C
    Brain Behav; 2019 Apr; 9(4):e01229. PubMed ID: 30806014
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Repetitive transcranial magnetic stimulation as an augmentative strategy for treatment-resistant depression, a meta-analysis of randomized, double-blind and sham-controlled study.
    Liu B; Zhang Y; Zhang L; Li L
    BMC Psychiatry; 2014 Nov; 14():342. PubMed ID: 25433539
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Brain Features of Treatment-Resistant Depression: A Review of Structural and Functional Connectivity Magnetic Resonance Imaging Studies.
    Grehl MM; Hameed S; Murrough JW
    Psychiatr Clin North Am; 2023 Jun; 46(2):391-401. PubMed ID: 37149352
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Functional connectivity of the anterior cingulate cortex predicts treatment outcome for rTMS in treatment-resistant depression at 3-month follow-up.
    Ge R; Downar J; Blumberger DM; Daskalakis ZJ; Vila-Rodriguez F
    Brain Stimul; 2020; 13(1):206-214. PubMed ID: 31668646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of thalamic hyperactivity with treatment-resistant depression and poor response in early treatment for major depression: a resting-state fMRI study using fractional amplitude of low-frequency fluctuations.
    Yamamura T; Okamoto Y; Okada G; Takaishi Y; Takamura M; Mantani A; Kurata A; Otagaki Y; Yamashita H; Yamawaki S
    Transl Psychiatry; 2016 Mar; 6(3):e754. PubMed ID: 26954981
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The role of transcranial magnetic stimulation in treatment-resistant depression: a review.
    Lee JC; Blumberger DM; Fitzgerald PB; Daskalakis ZJ; Levinson AJ
    Curr Pharm Des; 2012; 18(36):5846-52. PubMed ID: 22681165
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Abnormal neural activity of brain regions in treatment-resistant and treatment-sensitive major depressive disorder: a resting-state fMRI study.
    Guo WB; Liu F; Chen JD; Gao K; Xue ZM; Xu XJ; Wu RR; Tan CL; Sun XL; Liu ZN; Chen HF; Zhao JP
    J Psychiatr Res; 2012 Oct; 46(10):1366-73. PubMed ID: 22835912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Therapeutic Strategies for Treatment-resistant Depression: State of the Art and Future Perspectives.
    Goh KK; Chang SC; Chen CH; Lu ML
    Curr Pharm Des; 2020; 26(2):244-252. PubMed ID: 31924151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Augmenting antidepressants with deep transcranial magnetic stimulation (DTMS) in treatment-resistant major depression.
    Berlim MT; Van den Eynde F; Tovar-Perdomo S; Chachamovich E; Zangen A; Turecki G
    World J Biol Psychiatry; 2014 Sep; 15(7):570-8. PubMed ID: 25050453
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.